Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christof Bernemann

Showing results (21-30 of 42) with videos related to

Pageof 5
Sort By:
Seminars in Nuclear Medicine|April 2, 2026
The prostatic acid phosphatase in prostate cancer: A novel theranostic targetKonstantin Egon Seifert, Julissa Reimann, Martin Rust, et al.
Plos One|August 20, 2011
An RNA interference phenotypic screen identifies a role for FGF signals in colon cancer progressionMarc Leushacke, Ralf Spörle, Christof Bernemann, et al.
Cancer Treatment and Research Communications|July 4, 2020
Antibody selection influences the detection of AR-V7 in primary prostate cancerAdam Kaczorowski, Xin Chen, Esther Herpel, et al.
Nature Cell Biology|December 7, 2010
Direct reprogramming of fibroblasts into epiblast stem cellsDong Wook Han, Boris Greber, Guangming Wu, et al.
The Prostate|April 4, 2024
Development of a multigenomic liquid biopsy (PROSTest) for prostate cancer in whole bloodIrvin M Modlin, Mark Kidd, Ignat A Drozdov, et al.
Molecular Cancer|July 19, 2014
Influence of secreted frizzled receptor protein 1 (SFRP1) on neoadjuvant chemotherapy in triple negative breast cancer does not rely on WNT signalingChristof Bernemann, Carolin Hülsewig, Christian Ruckert, et al.
Cell Stem Cell|March 9, 2010
Conserved and divergent roles of FGF signaling in mouse epiblast stem cells and human embryonic stem cellsBoris Greber, Guangming Wu, Christof Bernemann, et al.
Scientific Reports|July 13, 2022
Comparison of circulating tumor cells and AR-V7 as clinical biomarker in metastatic castration-resistant prostate cancer patientsKatrin Schlack, Konstantin Seitzer, Neele Wüstmann, et al.
Journal of Translational Medicine|January 18, 2024
New advances of the androgen receptor in prostate cancer: report from the 1st International Androgen Receptor SymposiumSherif Mehralivand, Christian Thomas, Martin Puhr, et al.
Future Oncology (London, England)|May 30, 2019
Correlation between SFRP1 expression and clinicopathological parameters in patients with triple-negative breast cancerSarah Alexandra Schäfer, Carolin Hülsewig, Peter Barth, et al.
Pageof 5

Showing results (21-30 of 42) with videos related to

Sort By:
Pageof 5
Seminars in Nuclear Medicine|April 2, 2026
The prostatic acid phosphatase in prostate cancer: A novel theranostic targetKonstantin Egon Seifert, Julissa Reimann, Martin Rust, et al.
Plos One|August 20, 2011
An RNA interference phenotypic screen identifies a role for FGF signals in colon cancer progressionMarc Leushacke, Ralf Spörle, Christof Bernemann, et al.
Cancer Treatment and Research Communications|July 4, 2020
Antibody selection influences the detection of AR-V7 in primary prostate cancerAdam Kaczorowski, Xin Chen, Esther Herpel, et al.
Nature Cell Biology|December 7, 2010
Direct reprogramming of fibroblasts into epiblast stem cellsDong Wook Han, Boris Greber, Guangming Wu, et al.
The Prostate|April 4, 2024
Development of a multigenomic liquid biopsy (PROSTest) for prostate cancer in whole bloodIrvin M Modlin, Mark Kidd, Ignat A Drozdov, et al.
Molecular Cancer|July 19, 2014
Influence of secreted frizzled receptor protein 1 (SFRP1) on neoadjuvant chemotherapy in triple negative breast cancer does not rely on WNT signalingChristof Bernemann, Carolin Hülsewig, Christian Ruckert, et al.
Cell Stem Cell|March 9, 2010
Conserved and divergent roles of FGF signaling in mouse epiblast stem cells and human embryonic stem cellsBoris Greber, Guangming Wu, Christof Bernemann, et al.
Scientific Reports|July 13, 2022
Comparison of circulating tumor cells and AR-V7 as clinical biomarker in metastatic castration-resistant prostate cancer patientsKatrin Schlack, Konstantin Seitzer, Neele Wüstmann, et al.
Journal of Translational Medicine|January 18, 2024
New advances of the androgen receptor in prostate cancer: report from the 1st International Androgen Receptor SymposiumSherif Mehralivand, Christian Thomas, Martin Puhr, et al.
Future Oncology (London, England)|May 30, 2019
Correlation between SFRP1 expression and clinicopathological parameters in patients with triple-negative breast cancerSarah Alexandra Schäfer, Carolin Hülsewig, Peter Barth, et al.
Pageof 5